Chief Physician, Doctoral Supervisor
Affiliated HospitalRuijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
→
-Research areas : radionuclide therapy internal radiation dosimetry, organ radiation protection with radioligands, and tumor radionuclide targeted therapy.
- Cutting-edge technologies:¹⁷⁷Lu-PSMA SPECT/CT absorbed dose calculation; kidney and bone marrow radiation damage prediction models.
- Areas of expertise: Treatment of mCRPC¹⁷⁷Lu-PSMA, radionuclide therapy for differentiated thyroid cancer, and radionuclide analgesia for bone metastases of tumors.
- Academic Highlights: Member of the Radionuclide Therapy Group of the Nuclear Medicine Branch of the Chinese Medical Association, Head of the Shanghai Nuclear Medicine Radionuclide Therapy Group, and a leading authority in radionuclide internal irradiation dosimetry in China.
- Core Value: To build a personalized dosimetric assessment system for ¹⁷⁷Lu-PSMA to reduce the risk of treatment-related kidney and bone marrow toxicity.